Exenatide
EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
AstraZeneca · Phase 3 · Completed · Enrollment 119
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Exenatide once weekly (EQW ) | n/r | n/r | n/r | n/r | 0 |
| Dapagliflozin (DAPA) | n/r | n/r | n/r | n/r | 0 |
| EQW plus DAPA | n/r | n/r | n/r | n/r | 0 |
| Dapagliflozin plus Glucophage (MET ER) | n/r | n/r | n/r | n/r | 0 |
| Phentermine /Topiramate (PHEN/ TPM) ER | n/r | n/r | n/r | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.